中国医学计算机成像杂志
中國醫學計算機成像雜誌
중국의학계산궤성상잡지
CHINESE JOURNAL OF MEDICAL COMPUTED IMAGING
2009年
6期
532-535
,共4页
谭文莉%张安君%赵喜%龚志刚%俞健力%钟薏%詹松华
譚文莉%張安君%趙喜%龔誌剛%俞健力%鐘薏%詹鬆華
담문리%장안군%조희%공지강%유건력%종의%첨송화
磁共振成像%扩散加权成像%氟尿嘧啶%小鼠%肝细胞癌
磁共振成像%擴散加權成像%氟尿嘧啶%小鼠%肝細胞癌
자공진성상%확산가권성상%불뇨밀정%소서%간세포암
Magnetic resonance imaging%Diffusion-weighted imaging%Fluorouracil%Rats%Hepatocellular carcinoma
目的:探讨磁共振DWI成像技术在氟尿嘧啶治疗小鼠皮下移植肝癌疗效评价中的作用.方法:将小鼠随机分为两组,制备小鼠H22皮下种植肝癌模型.种植成功第5天后,A组隔天给予氟尿嘧啶腹腔注射,B组给予蒸馏水灌胃.第15天进行MR检查,测量肿瘤组织的表观扩散系数(ADC).检查完毕后处死小鼠,测量血清中血管生成因子(VEGF)水平;取瘤体及脾脏分别称重,计算肿瘤指数及脾脏指数;检测新鲜肿瘤组织肝癌细胞凋亡的DNA百分比.将两组小鼠的ADC值及实验室数据行t检验,分析两组小鼠ADC值与各实验室结果的相关性.结果:在扩散敏感因子(b)=600s/mm~2及1200s/mm~2的DWI图像中,肝癌多表现为高信号,其内的坏死部分为低信号.A组、B组肿瘤实质部分的ADC值分别为:780±122mm~2/s、596.50±80.17mm~2/s;1421 ±160mm~2/s、1232.804-85.02mm~2/s,两者具有统计学差异(P<0.05).肿瘤实质成分的ADC值与血清中VEGF水平、肝癌细胞凋亡的DNA百分比、处死后称得的瘤体及脾脏重量存在相关性.结论:ADC值可以反映氟尿嘧啶对肿瘤生长抑制的情况,MR DWI技术及ADC值在氟尿嘧啶治疗小鼠皮下移植肝癌疗效评价方面具有可行性.
目的:探討磁共振DWI成像技術在氟尿嘧啶治療小鼠皮下移植肝癌療效評價中的作用.方法:將小鼠隨機分為兩組,製備小鼠H22皮下種植肝癌模型.種植成功第5天後,A組隔天給予氟尿嘧啶腹腔註射,B組給予蒸餾水灌胃.第15天進行MR檢查,測量腫瘤組織的錶觀擴散繫數(ADC).檢查完畢後處死小鼠,測量血清中血管生成因子(VEGF)水平;取瘤體及脾髒分彆稱重,計算腫瘤指數及脾髒指數;檢測新鮮腫瘤組織肝癌細胞凋亡的DNA百分比.將兩組小鼠的ADC值及實驗室數據行t檢驗,分析兩組小鼠ADC值與各實驗室結果的相關性.結果:在擴散敏感因子(b)=600s/mm~2及1200s/mm~2的DWI圖像中,肝癌多錶現為高信號,其內的壞死部分為低信號.A組、B組腫瘤實質部分的ADC值分彆為:780±122mm~2/s、596.50±80.17mm~2/s;1421 ±160mm~2/s、1232.804-85.02mm~2/s,兩者具有統計學差異(P<0.05).腫瘤實質成分的ADC值與血清中VEGF水平、肝癌細胞凋亡的DNA百分比、處死後稱得的瘤體及脾髒重量存在相關性.結論:ADC值可以反映氟尿嘧啶對腫瘤生長抑製的情況,MR DWI技術及ADC值在氟尿嘧啶治療小鼠皮下移植肝癌療效評價方麵具有可行性.
목적:탐토자공진DWI성상기술재불뇨밀정치료소서피하이식간암료효평개중적작용.방법:장소서수궤분위량조,제비소서H22피하충식간암모형.충식성공제5천후,A조격천급여불뇨밀정복강주사,B조급여증류수관위.제15천진행MR검사,측량종류조직적표관확산계수(ADC).검사완필후처사소서,측량혈청중혈관생성인자(VEGF)수평;취류체급비장분별칭중,계산종류지수급비장지수;검측신선종류조직간암세포조망적DNA백분비.장량조소서적ADC치급실험실수거행t검험,분석량조소서ADC치여각실험실결과적상관성.결과:재확산민감인자(b)=600s/mm~2급1200s/mm~2적DWI도상중,간암다표현위고신호,기내적배사부분위저신호.A조、B조종류실질부분적ADC치분별위:780±122mm~2/s、596.50±80.17mm~2/s;1421 ±160mm~2/s、1232.804-85.02mm~2/s,량자구유통계학차이(P<0.05).종류실질성분적ADC치여혈청중VEGF수평、간암세포조망적DNA백분비、처사후칭득적류체급비장중량존재상관성.결론:ADC치가이반영불뇨밀정대종류생장억제적정황,MR DWI기술급ADC치재불뇨밀정치료소서피하이식간암료효평개방면구유가행성.
Purpose: To investigate the role of DWI technology in evaluating the effect of fluorouracil in H22 hepatoma rat model. Methods: A total of 20 rats were divided into 2 groups randomly. The H22 hepatocellular carcinoma rat models were established. Five days after successful cultivation, group A was treated by injecting fluorouracil intraperitoneally once of 2 days, group B was distilled water orally. Rats in each group were performed with MRI after 15 days. The apparent diffusion coefficient (ADC) of the tumor was measured and the images were observed. The rats were sacrificed after the exams were finished. The serum vascular endothelial growth factor(VEGF) level and the apoptosis of tumor cells were measured. The tumors and spleens were weighted to calculate tumor index and spleen index. The ADC value and the laboratory data of the two groups were compared with t test. The relationship of ADC value and the laboratory data was evaluated. Results: In DWI with b value = 600 and 1200mm~2/s, hepatocellular carcinoma displayed high signal, and the signal of necrosis was low. ADC values in solid parts of tumor in group A and group B were 780 ± 122mm~2/ s, 596.50 ± 80.17mm~2/ s and 1421 ± 160mm~2/ s, 1232.80 ± 85.02mm~2/s, respectively, and with significant difference (P < 0.05) . The ADC value of the parenchy-matous tissue of the tumor was correlation with the serum VEGF level, tumor cell apoptosis, and the weight of the tumor and spleen. Conclusion: ADC value can reflect the inhabitation of fluorouracil totumor growth. DWI technology and ADC value is a feasible method in evaluating of the effect of fluo-rouracil in the treatment of hepatocellular carcinoma transplanted subcutaneously in rats.